Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Transkaryotic preclinical data

TKT (Cambridge, Mass.) presented mouse data showing that the company has obtained long-term expression of EPO at therapeutic levels for up to one year with one injection.

The experiments are continuing to determine whether the procedure results

Read the full 373 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers